Adipose-Derived Stem Cells in Neurological Conditions: What Clinical Trials Are Investigating

Adipose-Derived Stem Cells in Neurological Conditions: What Clinical Trials Are Investigating

Adipose-Derived Stem Cells in Neurological Conditions: What Clinical Trials Are Investigating Neurological conditions, including spinal cord injury, traumatic brain injury, stroke, Alzheimer’s disease, and multiple sclerosis, represent some of the most challenging areas of modern medicine. The central nervous system has limited capacity for self-repair after injury or disease, and treatment options for many of […]

Adipose-Derived Stem Cells in Wound Healing and Tissue Repair: What Researchers Are Studying

Adipose-Derived Stem Cells in Wound Healing and Tissue Repair: What Researchers Are Studying

Chronic wounds affect approximately 8.2 million Americans, and diabetic foot ulcers alone are responsible for over 100,000 lower limb amputations each year. Adipose-derived stem cells (ADSCs) and their cell-free derivatives are among the most actively investigated regenerative approaches for wound healing. This guide covers published clinical trial results, 2025 meta-analyses, active trials on ClinicalTrials.gov, emerging […]

Adipose-Derived Stem Cells in Autoimmune and Inflammatory Disease Research: What the Science Shows

Adipose-Derived Stem Cells in Autoimmune and Inflammatory Disease Research: What the Science Shows

Autoimmune and inflammatory diseases affect millions of Americans, and many patients struggle with treatments that provide incomplete relief or carry significant side effects. Researchers are investigating whether adipose-derived mesenchymal stromal cells (ADSCs) could play a role in addressing these complex conditions. This guide walks through the current clinical evidence, the regulatory lessons learned from the […]

Adipose-Derived Stem Cells and Osteoarthritis: What Clinical Trials Are Investigating Right Now

Adipose-Derived Stem Cells and Osteoarthritis: What Clinical Trials Are Investigating Right Now

If you are exploring regenerative medicine options for osteoarthritis, understanding the current state of clinical research is essential before making any decisions. This guide provides a comprehensive, science-based overview of clinical trials studying adipose-derived stem cells for osteoarthritis, including trial phases, safety findings, regulatory context, and what this research landscape means for patients considering adipose […]

How to Spot Fake Stem Cell Clinics: Red Flags, FDA Warnings, and How to Find Legitimate Care

Red Flags: How to Spot Unethical Stem Cell Clinics and Protect Yourself

Hundreds of clinics across the United States market “stem cell therapy” directly to consumers for conditions ranging from arthritis to Alzheimer’s disease, often charging thousands to tens of thousands of dollars per treatment. Most of these offerings are unproven, unregulated, and have led to documented patient harms, including infections, vision loss, and even deaths. The […]

Mesenchymal Stem Cells 101: How Adipose‑Derived Cells Compare with Bone Marrow and Birth Tissue

Mesenchymal Stem Cells 101: How Adipose-Derived Cells Compare with Bone Marrow and Birth Tissue

Mesenchymal stem cells, often abbreviated MSCs, are a family of multipotent cells found in bone marrow, adipose (fat) tissue, umbilical cord, and other tissues throughout the body. These cells can differentiate into bone, cartilage, and fat under laboratory conditions and are being studied in hundreds of clinical trials for their regenerative and immunomodulatory properties. Each […]

Expanded Access Programs: How Patients Can Legally Access Investigational Therapies

Expanded Access Programs: How Patients Can Legally Access Investigational Therapies

Expanded Access, sometimes called compassionate use, is the FDA’s formal pathway for certain patients with serious or immediately life-threatening diseases to access investigational products outside of clinical trials when specific criteria are met. It is a regulated, structured process governed by federal law, and it is distinct from both clinical trials and “Right-to-Try” legislation. This […]

DISCLAIMER

Disclaimer, use of Outside Content:
Save My Fat, LLC does not endorse nor confirm that any of the following content that originated outside of Save My Fat, LLC, in any format such as an article, white paper, study, clinical trial(s), or other publication, constitutes double‑blind studies with a placebo or without, FDA‑approved IND clinical trials, or is associated with any FDA‑cleared 510(k) device. Such outside content may be influenced by subjective insight from the authors, medical doctors, PhDs, commercial influence, or any other contributors to the relevant research or content.

Save My Fat, LLC does not claim that any such outside content utilizes Save My Fat products, services, or protocols, and notes that manufacturing processes, techniques, or treatment methods referenced in that outside content may vary drastically and may not be FDA compliant.

This information is intended for licensed medical professionals only and is provided for educational and informational purposes; it is not medical advice, diagnosis, or treatment and in no way should this information be distributed to or relied upon by the general public.